I have this black line seens last 3 year and more,what is its diagnosis
longitudinal melanonychia subungual melanoma diagnosis
| Cause | Examples | Risk |
|---|---|---|
| Melanocyte activation (most common) | Trauma/friction, racial pigmentation, drugs, fungal infection, pregnancy | Low - benign |
| Benign melanocyte proliferation | Nail matrix nevus (mole), lentigo | Low - benign but monitor |
| Malignant proliferation | Subungual melanoma | Serious - must be ruled out |
See a dermatologist. This cannot be fully assessed from a photo alone.
Subungual melanoma
subungual melanoma diagnosis management
PMID: 36980308

| Mimic | Key distinguishing feature |
|---|---|
| Subungual hematoma | Moves distally as nail grows; history of trauma |
| Onychomycosis | Fungal culture positive; no linear band |
| Pyogenic granuloma | Fleshy, bleeds easily; no pigment band |
| Verruca vulgaris | Rough surface; no matrix origin |
| Glomus tumor | Intense point tenderness; subungual location |
| Kaposi sarcoma | Multiple lesions; known HIV/immunosuppression |
| Chronic paronychia | Inflammation around fold; no longitudinal band |
| Letter | Criterion |
|---|---|
| A | Age 40-70 years; African-American, Asian, Native American ethnicity |
| B | Band: Brown-black, breadth >3 mm, blurred or irregular border |
| C | Change: Rapid increase in width, color change, nail dystrophy not improving with treatment |
| D | Digit: Thumb > big toe > index; single digit involvement |
| E | Extension: Hutchinson sign (pigment on proximal/lateral nail fold) |
| F | Family or personal history of melanoma or dysplastic nevi |
| Stage | Treatment |
|---|---|
| In situ / early invasive | Wide local excision with digit preservation |
| Advanced invasive | Distal digit amputation (remains standard) |
| Hutchinson sign (in situ spread) | Topical imiquimod immunotherapy |
| Metastatic / advanced | Targeted therapy (BRAF/MEK inhibitors if BRAF-mutated), immune checkpoint inhibitors (anti-PD-1, anti-CTLA-4) |
Note: BRAF mutations are less common in acral/subungual melanoma than in cutaneous melanoma, so BRAF inhibitors benefit fewer patients. KIT mutations are more common and may respond to imatinib. - Conway et al., 2023
Subungual melanoma is "not particularly aggressive - it is the delay in diagnosis and treatment that makes the prognosis so poor." - Fitzpatrick's Dermatology
Image
What is you probably diagnosis
| Feature | Finding | Significance |
|---|---|---|
| Band type | Longitudinal, base to tip | Classic melanonychia |
| Color | Very dark brown-black | Higher suspicion |
| Width | ~15-20% of nail width | >3 mm = ABCDEF "B" criterion met |
| Borders | Sharp, parallel, well-defined | Somewhat reassuring |
| Color uniformity | Solid and uniform | Could be benign nevus |
| Nail plate | Intact, no dystrophy | Reassuring - not advanced |
| Proximal nail fold | Possible small pigmented smudge at cuticle | Possible Hutchinson sign - concerning |
| Scenario | Action needed |
|---|---|
| Nail matrix nevus | Monitoring every 6 months, possible biopsy for certainty |
| Subungual melanoma in situ | Wide excision with digit preservation - excellent cure rate |
| Invasive melanoma | Surgical amputation of distal digit + staging |
You cannot safely distinguish a nevus from early subungual melanoma by clinical appearance alone - not even dermatologists can without dermoscopy and biopsy.